Active, not recruitingEarly Phase 1NCT03164486

First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide

Studying Chronic bilirubin encephalopathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Julie L. Sutcliffe, Ph.D
Principal Investigator
Julie Sutcliffe
University of California, Davis
Intervention
18F-αvβ6-BP(drug)
Enrollment
27 enrolled
Eligibility
18 years · All sexes
Timeline
2016 – 2026

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03164486 on ClinicalTrials.gov

Other trials for Chronic bilirubin encephalopathy

Additional recruiting or active studies for the same condition.

See all trials for Chronic bilirubin encephalopathy →

← Back to all trials